Trial intelligence / Profile preview

Losartan vs Atenolol in Adults With Marfan Syndrome

NCT00723801Phase 3Completed

Sponsor
Brigham and Women's Hospital
Start
Oct 2007
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of losartan in Marfan syndrome (MFS), sponsored by Brigham and Women's Hospital. Started Oct 2007; status: completed.

02

Drugs

losartan
03

Conditions

Marfan syndrome (MFS)

Beyond the preview

Go deeper on NCT00723801.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00723801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call